Charles River Laboratories International Inc (CRL)
195.77
+1.58
(+0.81%)
USD |
NYSE |
Nov 22, 16:00
195.80
+0.03
(+0.02%)
Pre-Market: 20:00
Charles River Laboratories International Total Liabilities (Quarterly): 4.176B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 4.176B |
| June 30, 2024 | 4.175B |
| March 31, 2024 | 4.449B |
| December 31, 2023 | 4.536B |
| September 30, 2023 | 4.256B |
| June 30, 2023 | 4.472B |
| March 31, 2023 | 4.543B |
| December 31, 2022 | 4.579B |
| September 30, 2022 | 4.711B |
| June 30, 2022 | 4.836B |
| March 31, 2022 | 4.404B |
| December 31, 2021 | 4.432B |
| September 30, 2021 | 4.594B |
| June 30, 2021 | 4.366B |
| March 31, 2021 | 3.593B |
| December 31, 2020 | 3.347B |
| September 30, 2020 | 3.288B |
| June 30, 2020 | 3.460B |
| March 31, 2020 | 3.522B |
| December 31, 2019 | 3.026B |
| September 30, 2019 | 3.018B |
| June 30, 2019 | 3.147B |
| March 31, 2019 | 2.505B |
| December 31, 2018 | 2.518B |
| September 30, 2018 | 2.523B |
| Date | Value |
|---|---|
| June 30, 2018 | 2.664B |
| March 31, 2018 | 1.841B |
| December 31, 2017 | 1.866B |
| September 30, 2017 | 1.825B |
| June 30, 2017 | 1.792B |
| March 31, 2017 | 1.803B |
| December 31, 2016 | 1.858B |
| September 30, 2016 | 1.802B |
| June 30, 2016 | 1.901B |
| March 31, 2016 | 1.291B |
| December 31, 2015 | 1.303B |
| September 30, 2015 | 1.297B |
| June 30, 2015 | 1.150B |
| March 31, 2015 | 1.150B |
| December 31, 2014 | 1.166B |
| September 30, 2014 | 1.144B |
| June 30, 2014 | 1.165B |
| March 31, 2014 | 931.50M |
| December 31, 2013 | 968.10M |
| September 30, 2013 | 969.74M |
| June 30, 2013 | 959.21M |
| March 31, 2013 | 963.94M |
| December 31, 2012 | 983.14M |
| September 30, 2012 | 967.67M |
| June 30, 2012 | 981.22M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.026B
Minimum
Dec 2019
4.836B
Maximum
Jun 2022
4.138B
Average
4.385B
Median
Total Liabilities (Quarterly) Benchmarks
| Boston Scientific Corp | 17.12B |
| CVS Health Corp | 177.32B |
| Arbutus Biopharma Corp | 33.55M |
| FibroBiologics Inc | 7.732M |
| Biomarin Pharmaceutical Inc | 1.438B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.004B |
| Shareholders Equity (Quarterly) | 3.782B |
| Debt to Equity Ratio | 0.6151 |
| Current Ratio | 1.477 |
| Net Debt Paydown Yield | 0.70% |